FDA NDC Directory · JSON-LD · Markdown

AIMOVIG

NDC 55513-842 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic nameerenumab-aooe
Labeler / ManufacturerAmgen Inc
Marketing categoryBiologic License Application · App BLA761077
Dosage form / routeINJECTION, SOLUTION · SUBCUTANEOUS
Active ingredientsERENUMAB (140 mg/mL)
Marketing started20190315
Package count1

External sources

Source: openFDA. Public-domain (CC0).